)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Evonik Industries
Evonik Industries (EVK) investor relations material
Evonik Industries Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary3 Nov, 2026
Executive summary
Q3 sales rose 13% YoY to €3,825m and adjusted EBITDA increased 40% to €629m, with margin expanding to 16.4%.
FY 2026 adjusted EBITDA is expected in the upper half of the €2.0–2.2bn guidance range; 2026 ROCE guidance is above 8%, with a ~11% target by 2029.
Strategy focuses the portfolio and lowers capital intensity; management declined to negotiate on the BASF approach based on information received so far, while planning a confidential exchange.
Financial highlights
Q3 adjusted EBIT rose 97% to €389m; adjusted net income increased 158% to €330m and adjusted EPS was €0.71.
9M sales grew 4% to €11,144m; adjusted EBITDA rose 14% to €1,734m and adjusted EBIT increased 31% to €994m.
9M reported net income fell 37% to €156m from €247m, mainly reflecting structural-measure expenses.
Q3 free cash flow was €369m versus €300m; 9M free cash flow more than doubled to €601m from €284m.
Outlook and guidance
FY 2026 free cash flow is expected at ~€850m, with cash conversion near 40%, versus 37% in 2025.
FY 2026 ROCE guidance was raised to >8%, compared with 6.1% in 2025; Q4 earnings are expected to grow YoY despite normal seasonality.
FY investment cash outflows are expected at ~€750m; adjusted D&A is expected slightly below 2025’s €1,013m.
FY adjusted tax rate is expected near 20%, revised from ~25%; the 2027 tax rate is expected at ~25%.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Evonik Industries
- Q3 EBITDA rose 40% as 9M FCF doubled, supporting an ~11% ROCE target by 2029.EVK
Company presentation - Q2 2026 EBITDA up 24%, FY outlook raised, and new dividend policy introduced.EVKCompany presentation
- Q2 2026 adjusted EBITDA up 24% to €630M; full-year guidance raised amid strong segment gains.EVKQ2 2026
- Integrated innovation and sustainability drive growth in biosolutions, hydrogen, and recycling.EVKInvestor update
- Leadership changes, new dividend policy, and innovation-driven strategy amid global challenges.EVKAGM 2026
- Q1 2026 EBITDA exceeded forecasts, but sales and net income fell; outlook remains stable.EVKQ1 2026
- Q3 adjusted EBITDA up 19%, margin at 15%, and 2024 outlook confirmed amid uncertainty.EVKQ3 2024
- Despite a tough year, stable dividends and strategic transformation were maintained.EVKAGM 2024
- Targeting €1bn EBITDA growth and 11% ROCE by 2027 through innovation, optimization, and sustainability.EVKCMD 2025
Next Evonik Industries earnings date
Q4 20264 Mar, 2027
Evonik Industries
Next Evonik Industries earnings date
Q4 20264 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Evonik Industries AG engages in the specialty chemicals business. It operates through the following segments: Nutrition & Care, Resource Efficiency, Performance Materials and Services. The Nutrition & Care segment provide products and services for the global nutrition, health, beauty and personal care markets, as well as medical applications. The Resource Efficiency segment focuses on products and services for the construction sector, including plastics for windows and doors; it also supplies catalysts and adsorbents to the oil refining industry; gets involved in engineering services for chemical equipment design. The Performance Materials segment involves in advanced intermediates for coatings; makes additives for plastics production; offers aerogel insulation products. The Services segment comprises of animal health services; supplies fuel additives to gas stations; makes equine breeding products as well as sensors to check/reduce emissions from vehicles.